3.06

1.61% -0.05

Grace Therapeutics Inc (GRCE)

Overview News Price History Discussions Forecast

Grace Therapeutics Inc stock is traded at $3.06, with a volume of 29,293. It is down -1.61% in the last 24 hours and up +1.16% over the past month. Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage. Other products are GTx-102 Ataxia-Telangiectasia, GTx-101 Postherpetic Neuralgia, and GTx-201.

Previous Close:

$3.11

Open:

$3.1

24h Volume:

29,293

Relative Volume:

0.36

Market Cap:

$42.32M

Revenue:

Net Income/Loss:

$-10.31M

P/E Ratio:

-3.974

EPS:

-0.77

Net Cash Flow:

$-12.65M

1W Performance:

-4.08%

1M Performance:

+1.16%

6M Performance:

+0.82%

1Y Performance:

-2.39%

1-Day Range:

$3.05

$3.12

1-Week Range:

$3.05

$3.24

52-Week Range:

$1.75

$4.965

Grace Therapeutics Inc Stock (GRCE) Company Profile

Name

Grace Therapeutics Inc

Sector

Healthcare (1141)

Industry

Biotechnology (633)

Phone

609-322-1602

Address

103 CARNEGIE CENTER, PRINCETON

Employee

Twitter

Next Earnings Date

Latest SEC Filings

GRCE's Discussions on Twitter

Compare GRCE with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
GRCE Grace Therapeutics Inc	3.06	47.19M	0	-10.31M	-12.65M	-0.77
VRTX Vertex Pharmaceuticals Inc	428.42	109.22B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	631.32	67.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	426.61	57.35B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	842.02	50.87B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	183.88	39.72B	447.02M	-1.18B	-868.57M	-6.1812

Grace Therapeutics Inc Stock (GRCE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-02-25	Initiated	TD Cowen	Buy
Sep-01-20	Downgrade	Oppenheimer	Outperform → Perform
Jul-06-20	Upgrade	B. Riley FBR	Neutral → Buy
Jan-13-20	Downgrade	B. Riley FBR	Buy → Neutral
Aug-29-19	Initiated	B. Riley FBR	Buy
Jul-18-19	Initiated	Oppenheimer	Outperform
Jun-26-19	Initiated	H.C. Wainwright	Buy

View All

Grace Therapeutics Inc Stock (GRCE) Latest News

07:03 AM

Can Grace Therapeutics Inc. stock rebound after recent weaknessRate Hike & Breakout Confirmation Alerts - newser.com

07:03 AM

04:16 AM

Why Grace Therapeutics Inc. stock could rally in 2025Weekly Risk Report & Weekly Top Gainers Trade List - newser.com

04:16 AM

03:49 AM

Published on: 2025-11-04 02:49:13 - newser.com

03:49 AM

02:34 AM

Will Grace Therapeutics Inc. stock outperform value stocksWeekly Trade Analysis & Consistent Growth Stock Picks - newser.com

02:34 AM

Nov 03, 2025

Why Grace Therapeutics Inc. stock remains on watchlistsJuly 2025 Rallies & Daily Chart Pattern Signals - newser.com

Nov 03, 2025

Grace Therapeutics Inc. stock outlook for YEAR2025 Price Momentum & Fast Gain Stock Trading Tips - newser.com

Nov 03, 2025

Using RSI to spot recovery in Grace Therapeutics Inc.Market Sentiment Review & Safe Capital Preservation Plans - newser.com

Nov 03, 2025

Will Grace Therapeutics Inc. stock outperform Nasdaq indexMarket Trend Review & Low Drawdown Trading Techniques - newser.com

Nov 03, 2025

Is Grace Therapeutics Inc. forming a bottoming basePortfolio Return Report & AI Powered Market Entry Ideas - newser.com

Nov 03, 2025

Can Grace Therapeutics Inc. stock resist market sell offsInsider Selling & Reliable Breakout Forecasts - newser.com

Nov 03, 2025

Is Grace Therapeutics Inc. stock a safe haven assetJuly 2025 Drop Watch & Accurate Intraday Trading Signals - newser.com

Nov 03, 2025

Nov 02, 2025

Building trade automation scripts for Grace Therapeutics Inc.2025 Institutional Moves & Growth Focused Stock Pick Reports - newser.com

Nov 02, 2025

Is this a good reentry point in Grace Therapeutics Inc.Gap Up & Low Risk Entry Point Guides - newser.com

Nov 02, 2025

Published on: 2025-11-02 05:34:07 - newser.com

Nov 02, 2025

Is Grace Therapeutics Inc. stock attractive for growth ETFsProfit Target & AI Based Trade Execution Alerts - newser.com

Nov 02, 2025